Related Experiment Videos
Thalassemia: lung function with reference to iron studies and reactive oxidant status
D K Luyt1, G A Richards, H Roode
1Department of Pediatrics, Coronation Hospital, Johannesburg, South Africa.
Pediatric Hematology and Oncology
|January 1, 1993
Summary
Thalassemia patients often show restrictive lung function abnormalities. However, neutrophil-derived oxygen free radicals do not appear to be a primary cause of these lung issues in individuals receiving transfusions and desferrioxamine.
Area of Science:
- Pulmonary Medicine
- Hematology
- Cellular Biology
Background:
- Thalassemia is a genetic blood disorder requiring regular transfusions.
- Desferrioxamine is used for iron chelation in thalassemic patients.
- Lung function abnormalities are a potential complication in thalassemia.
Purpose of the Study:
- To assess pulmonary function in thalassemic patients on regular transfusions and desferrioxamine.
- To investigate the role of neutrophil reactive oxidant production in lung damage in these patients.
Main Methods:
- Pulmonary function tests (PFTs) were conducted on 15 thalassemic patients.
- Measurement of reactive oxidant production from neutrophils.
- Correlation analysis between PFTs, clinical data, and neutrophil function.
Main Results:
- Significant reductions in total lung capacity, residual volume, and forced vital capacity were observed, indicating restrictive lung disease.
- Low carbon monoxide diffusion and hypoxemia were noted in a subset of patients.
- Pulmonary function abnormalities did not correlate with age, transfusion volume, serum ferritin, or neutrophil oxidant status.
Conclusions:
- Thalassemic patients on regular transfusions and desferrioxamine exhibit restrictive lung function abnormalities.
- Neutrophil-derived oxygen free radicals do not appear to be a major causative factor in these lung function impairments.